venezuelan
equin
enceph
viru
veev
belong
alphaviru
genu
within
togavirida
famili
first
isol
hors
end
virus
natur
transmiss
cycl
rodent
mosquito
million
hors
affect
arboviru
fatal
rate
epidem
central
south
america
sever
speci
famili
pathogen
human
recogn
potenti
biolog
warfar
agent
bwa
veev
classifi
bioterror
agent
categori
b
center
diseas
control
cdc
alphavirus
potenti
ill
transmiss
also
produc
larg
quantiti
moder
easi
dissemin
furthermor
viru
speci
capac
caus
human
epidem
veev
caus
diseas
symptom
rang
mild
febril
reaction
fatal
encephalit
zoonos
outcom
significantli
wors
young
elderli
patient
case
fatal
rang
virus
highli
infecti
aerosol
intent
releas
suffici
quantiti
inhal
smallparticl
aerosol
expect
infect
high
percentag
individu
within
area
least
replic
cell
cultur
high
titer
rel
stabl
environment
influenc
surveil
possibl
bioterror
target
endang
popul
rapid
detect
diagnosi
veev
crucial
import
past
gener
monoclon
murin
antibodi
improv
fast
identif
veev
infect
locat
human
equin
outbreak
enceph
hand
monospecif
diagnost
monoclon
antibodi
mab
veev
either
hardli
avail
market
expens
extens
use
view
current
limit
gener
specif
high
affin
recombin
antibodi
may
significantli
improv
current
situat
make
rapid
immunolog
detect
wide
avail
promis
method
gener
recombin
antibodi
human
pathogen
virus
like
veev
antibodi
phage
display
technolog
use
antibodi
phage
display
genotyp
phenotyp
antibodi
fragment
link
fuse
antibodi
gene
fragment
minor
coat
protein
iii
gene
filament
bacteriophag
result
antibodi
fragment
piii
fusion
protein
display
surfac
phage
particl
common
antibodi
format
use
technolog
fragment
antigen
bind
fab
singl
chain
fragment
variabl
scfv
comparison
fab
consist
fragment
determin
fd
heavi
chain
light
chain
link
disulphid
bond
scfv
simpli
consist
variabl
region
heavi
chain
vh
variabl
region
light
chain
vl
connect
short
peptid
linker
select
antibodi
fragment
antibodi
gene
librari
perform
vitro
select
process
also
refer
pan
studi
demonstr
select
human
antibodi
fragment
antibodi
gene
librari
specif
detect
veev
describ
immunolog
properti
discuss
possibl
applic
antibodi
diagnosi
detect
veev
potenti
bioterror
assault
natur
outbreak
veev
order
gener
antibodi
fragment
reactiv
member
vee
viru
serocomplex
human
naiv
scfv
antibodi
gene
librari
use
pan
perform
biosafeti
level
laboratori
vaccin
strain
medic
import
epizoot
alphaviru
speci
use
antigen
phage
librari
subject
round
pan
repres
phage
clone
assess
abil
bind
veev
immobil
onto
microwel
plate
order
exclud
enrich
falseposit
phage
bind
supernat
noninfect
vero
cell
vr
concentr
unconcentr
determin
furthermor
nonspecif
bind
scfv
phage
veevspecif
captur
antibodi
mab
mab
veewi
without
nonspecif
antigen
like
lysozym
examin
shown
figur
signific
enrich
veevspecif
polyclon
antibodi
phage
occur
third
pan
round
howev
besid
specif
accumul
binder
also
sever
coenrich
antibodi
captur
antibodi
observ
singl
clone
isol
third
pan
round
solubl
scfv
produc
microtitr
plate
analyz
antigen
elisa
immobil
inactiv
veev
particl
elisa
analysi
use
solubl
scfv
instead
scfv
phage
minim
occur
fals
posit
antibodi
fragment
bind
antibodi
phage
particl
inactiv
veev
particl
use
ensur
antibodi
select
activ
veev
particl
bound
inactiv
viru
initi
test
observ
enrich
antibodi
bind
vero
cell
cultur
compon
effect
enhanc
veev
particl
directli
coat
onto
well
captur
antibodi
therefor
vr
purifi
vero
cell
cultur
supernat
non
viru
infect
cell
use
protein
cell
cultur
supernat
also
enrich
vr
system
total
antibodi
clone
analyz
antigen
elisa
data
shown
due
signal
nois
ratio
veev
bind
scfv
clone
subject
bstni
fingerprint
sort
clone
ident
restrict
pattern
data
shown
dna
sequenc
differ
scfv
final
found
pan
design
one
addit
scfv
clone
isol
slightli
differ
pan
strategi
interestingli
antibodi
lambda
light
chain
obtain
accord
integr
databas
germlin
variabl
gene
immunoglobulin
loci
human
isol
scfv
fragment
contain
antigenbind
variabl
domain
light
chain
heavi
chain
isol
scfv
belong
subfamili
predomin
tabl
order
prove
present
function
scfv
select
monoclon
scfv
phage
clone
clone
subject
immunoblot
analysi
scfv
phage
separ
sdspage
reduc
condit
correspond
immunoblot
stain
use
antipiii
mab
scfv
phage
prepar
show
nearli
equal
effici
display
scfv
antibodi
surfac
straightli
allow
compar
cognat
elisa
western
blot
immunohistochemistri
result
antipiii
immunoblot
select
antiveev
scfv
phage
shown
figur
order
evalu
whether
antibodi
format
design
influenc
specif
bind
capac
elisa
result
obtain
select
scfv
phage
figur
correspond
scfvfc
fusion
figur
compar
purifi
formalin
inactiv
veev
antigen
immobil
onto
microwel
serial
dilut
either
antiveev
scfv
phage
serial
dilut
scfvfc
fusion
protein
use
detect
select
scfv
phage
clone
correspond
scfvfc
fusion
abl
bind
directli
immobil
veev
particl
figur
background
bind
control
antibodi
scfv
phage
increas
use
high
scfv
phage
particl
concentr
scfv
phage
concentr
scfv
phage
particl
respect
ngml
scfvfc
fusion
protein
well
suit
detect
immobil
veev
particl
addit
also
possibl
detect
direct
immobilis
activ
veev
particl
elisa
use
scfv
phage
figur
respect
scfvfc
fusion
protein
figur
sdspage
western
blot
valuabl
approach
examin
veev
structur
protein
recogn
select
antiveev
antibodi
fragment
sinc
viral
glycoprotein
separ
nonreduc
condit
viru
sampl
first
disintegr
incub
minut
laemmli
sampl
buffer
contain
sampl
separ
sdspage
blot
onto
pvdf
membran
stain
describ
gener
antiveev
scfv
phageml
use
specif
detect
structur
protein
fig
protein
specif
antibodi
mab
chemicon
ca
usa
mab
greiserwilk
et
al
serv
posit
control
display
expect
electrophoret
profil
typic
alphaviru
protein
kda
cognat
viral
heterodim
kda
interestingli
non
reduc
condit
antiveev
scfv
phage
display
nearli
similar
bind
pattern
abl
bind
either
glycoprotein
correspond
heterodim
figur
howev
sever
specif
scfv
phage
also
caus
undefin
smear
use
immunoblot
analysi
might
explain
prolong
stain
correspond
scfvfc
fusion
use
bind
clear
defin
band
repres
either
protein
detect
similar
glycoprotein
posit
control
figur
contrast
viru
sampl
either
prepar
reduc
condit
boil
prior
sdspage
specif
bind
observ
therefor
epitop
recogn
scfv
phage
scfvfc
fusion
like
conform
depend
secondari
structur
seem
critic
bind
viral
structur
protein
none
isol
scfv
fragment
identifi
linear
epitop
order
test
crossreact
select
antibodi
clone
strain
veev
well
antigen
complex
bind
evalu
sandwich
antigen
catch
elisa
use
alphaviru
specif
mab
mixtur
captur
select
scfv
phage
detect
establish
veevspecif
figur
alphaviru
genusspecif
sandwich
elisa
figur
serv
posit
control
neg
control
cell
cultur
noninfect
vero
cell
use
marker
antibodi
biotinyl
antiveev
mab
use
detect
veev
strain
figur
biotinyl
mixtur
antibodi
consist
mab
mab
mab
mab
use
group
specif
detect
alphavirus
figur
viral
antigen
captur
either
veevspecif
mab
mab
mixtur
antialphaviru
antibodi
consist
mab
mab
mab
wi
munster
germani
viru
strain
captur
better
other
veev
antigen
employ
nearli
similar
addit
veev
vaccin
strain
subtyp
iab
ussr
russian
vaccin
strain
veev
british
ncpv
strain
veev
appli
furthermor
select
scfv
clone
test
specif
detect
eastern
equin
enceph
viru
eeev
strain
western
equin
enceph
viru
weev
strain
chikungunya
viru
chikv
strain
petersfield
posit
elisa
signal
obtain
differ
veev
strain
test
scfv
phage
clone
figur
contrast
scfv
show
compar
low
antigen
bind
maximum
bind
antigen
sandwich
elisa
found
russian
strain
veev
might
explain
fact
viru
sampl
chemic
inactiv
prior
use
suppos
depend
inactiv
critic
epitop
access
antibodi
detect
howev
none
select
antiveev
scfv
phage
show
crossreact
alphavirus
use
detect
antibodi
posit
control
exhibit
expect
bind
pattern
captur
detect
specif
mab
elisa
order
examin
broad
immunolog
applic
select
scfv
also
test
recombin
antibodi
fragment
specif
detect
veev
lysat
infect
vero
cell
cell
lysat
prepar
disrupt
infect
cell
urea
coupl
microwel
detect
perform
scfv
phage
follow
incub
mab
conjug
hrp
lysat
noninfect
vero
cell
veev
antigen
incub
mab
serv
neg
control
specif
bind
could
confirm
nearli
select
antibodi
fragment
except
clone
stringent
bind
result
obtain
scfv
clone
fig
addit
detect
veevspecif
antigen
immunohistochemistri
infect
formaldehyd
fix
vero
cell
possibl
similar
result
describ
scfv
clone
except
clone
show
specif
cytoplasm
immunostain
veev
infect
vero
cell
data
shown
detect
veev
potenti
bioterrorim
assault
eg
use
veev
aerosol
natur
outbreak
veev
fast
diagnosi
pathogen
necessari
present
work
describ
first
time
screen
isol
antiveev
antibodi
fragment
human
antibodi
gene
librari
phage
display
ten
eleven
scfv
clone
select
pan
strategi
use
mab
mixtur
viru
captur
describ
one
clone
isol
altern
pan
perform
directli
immobil
viral
antigen
use
antibodi
captur
viru
particl
prefer
pan
strategi
preliminari
test
reveal
pan
directli
immobil
veev
antigen
enhanc
especi
enrich
nonspecif
binder
knowledg
studi
demonstr
success
vitro
antibodi
select
human
pathogen
complet
viru
particl
use
antibodi
gene
librari
success
pan
sever
acut
respiratori
syndrom
coronaviru
use
human
semisynthet
librari
describ
van
den
brink
et
al
studi
recombin
purifi
viru
protein
use
pan
use
antibodi
gene
librari
pan
use
complet
particl
mostli
perform
use
immun
librari
eg
de
carvalho
et
al
koch
et
al
duan
et
al
pan
procedur
describ
might
also
use
vitro
antibodi
select
scfv
viral
target
human
antibodi
gene
librari
particular
either
immun
patient
avail
immunis
ethic
feasibl
nearli
scfv
abl
detect
activ
well
inact
veev
viral
antigen
compar
indirect
elisa
data
obtain
scfv
phage
correspond
scfvfc
fusion
specif
immunoreact
could
verifi
western
blot
analysi
immunohistochemistri
immunostain
urea
disrupt
cell
lysat
select
antibodi
clone
reactiv
test
member
vee
viru
serocomplex
show
signific
crossreact
close
relat
alphaviru
speci
like
weev
eeev
chikv
use
detect
molecul
alphavirus
share
number
structur
sequenti
function
similar
immunolog
type
approach
categor
nearli
speci
seven
serocomplex
speci
nucleotid
amino
acid
ident
among
antigen
complex
subtyp
varieti
vari
gener
sequenc
structur
protein
diverg
sequenc
nonstructur
protein
immunoblot
analysi
antiveev
scfv
phage
display
similar
bind
pattern
like
protein
specif
antibodi
mab
chemicon
ca
usa
mab
identifi
probabl
glycoprotein
cognat
viral
heterodim
interestingli
obtain
scfv
clone
identifi
structur
epitop
still
fold
denatur
nonreduc
condit
contrast
viral
antigen
either
prepar
reduc
condit
boil
prior
sdspage
specif
bind
observ
possibl
neutralis
activ
select
scfv
assess
studi
normal
protect
immun
alphavirus
associ
antibodi
reactiv
virion
glycoprotein
far
six
conform
stabl
epitop
identifi
critic
viru
neutral
furthermor
antibodi
fulli
human
therefor
better
suit
applic
like
passiv
vaccin
murin
antibodi
date
veev
diagnosi
perform
use
monoclon
polyclon
antibodi
also
scfv
fragment
analys
studi
show
scfv
phage
applic
broad
rang
antiveev
diagnosi
assay
antigen
elisa
purifi
viru
particl
elisa
cell
lysat
immunoblot
furthermor
recombin
fragment
offer
possibl
develop
veevspecif
diagnosi
assay
sinc
specif
scfv
phage
easili
produc
purifi
high
amount
could
altern
fullsiz
igg
elisa
assay
least
might
appli
immunopcr
order
increas
sensit
detect
method
use
diagnosi
veev
enviro
detect
human
equin
veev
infect
first
time
studi
describ
select
antibodi
human
pathogen
viru
human
scfv
antibodi
gene
librari
use
complet
activ
viru
particl
antigen
describ
antibodi
select
procedur
may
also
use
vitro
antibodi
select
antibodi
fragment
viral
target
human
antibodi
gene
librari
particular
immun
patient
avail
immunis
ethic
feasibl
broad
sensit
applic
antiveev
scfvpresent
phage
immunolog
detect
diagnosi
alphaviru
speci
demonstr
select
recombin
antibodi
fragment
improv
rapid
specif
detect
veev
infect
human
equin
outbreak
enceph
earli
definit
identif
critic
import
alphavirus
grown
vero
cell
african
green
monkey
kidney
cell
dsmzacc
deutsch
sammlung
von
mikroorganismen
und
zellkulturen
gmbh
braunschweig
germani
biosafeti
level
facil
accord
standard
procedur
viru
titer
determin
tissu
cultur
infect
dose
method
virus
use
studi
repres
model
biowarfar
agent
relev
alphaviru
speci
either
part
strain
collect
arm
forc
scientif
institut
protect
technolog
nbc
protect
wi
receiv
nation
collect
pathogen
virus
ncpv
uk
virus
use
studi
veev
strain
varieti
veev
strain
eastern
equin
enceph
viru
eeev
strain
western
equin
enceph
viru
weev
strain
chikungunya
viru
chikv
strain
strain
obtain
trinidad
donkey
strain
serial
passag
guinea
pig
embryo
heart
cell
addit
veev
strain
antigen
inactiv
purchas
senova
gmbh
jena
germani
strain
veev
former
ussr
vaccin
strain
histori
product
exactli
known
produc
serial
passag
virul
natur
strain
chick
embryo
particularili
indic
activ
viru
materi
use
throughout
studi
lysat
veev
infect
cell
prepar
incub
urea
min
room
temperatur
rt
viru
contain
supernat
infect
vero
cell
either
purifi
affin
chromatographi
matrex
cellufin
sulfat
viru
recoveri
system
vr
chisso
america
inc
ny
usa
isopycn
densiti
gradient
centrifug
matrex
cellufin
sulfat
vr
cellulos
bead
medium
function
low
concentr
sulfat
ester
oper
similar
cationexchang
resin
high
affin
envelop
virus
select
adsorb
complet
viru
particl
well
viral
coat
accord
charg
briefli
ml
resin
equilibr
adsorpt
buffer
phosphat
buffer
ph
ml
viru
contain
prefilt
cell
cultur
supernat
load
onto
column
wash
twice
phosphat
buffer
ph
elut
viru
particl
perform
nacl
viru
particl
prepurifi
use
ultracentrifug
sucros
cushion
method
sucros
cushion
caus
low
mechan
stress
allow
concentr
collect
morpholog
intact
particl
centrifug
g
hour
pellet
resuspend
ml
phosphat
buffer
salin
pb
purifi
isopycn
densiti
gradient
centrifug
sucros
hour
g
viru
contain
fraction
remov
store
subject
analysi
pan
procedur
base
protocol
hust
et
al
numer
modif
well
microtitr
plate
maxisorb
nunc
wiesbaden
germani
mab
chemicon
temecula
usa
mab
wi
munster
germani
incub
concentr
overnight
microtitr
well
follow
block
wv
bsa
pbst
phosphat
buffer
salin
tween
h
rt
everi
pan
round
one
well
coat
select
one
well
coat
preselect
step
preselect
step
vr
concentr
supernat
noninfect
vero
cell
bsa
pbst
incub
afterward
well
block
skim
milk
powder
pbst
h
rt
well
wash
three
time
pbst
parallel
select
vr
purifi
veev
mgml
bsa
pbst
captur
h
gentli
shake
rt
follow
overnight
incub
human
antibodi
gene
librari
consist
independ
clone
total
base
phagemid
vector
use
pan
librari
packag
use
hyperphag
prior
pan
scfv
phage
particl
kappa
vl
repertoir
scfv
phage
particl
lambda
vl
repertoir
mix
panningblock
solut
wv
bsa
wv
skim
milk
pbst
preselect
step
librari
phage
suspens
incub
rt
h
well
captur
vr
concentr
supernat
noninfect
vero
cell
remov
nonspecif
binder
supernat
contain
deplet
librari
mix
volum
vr
concentr
supernat
noninfect
vero
cell
non
veevspecif
murin
igg
competit
select
step
librari
solut
incub
well
immobilis
veev
rt
h
follow
time
wash
pbst
afterward
bound
scfv
phage
particl
elut
trypsin
solut
trypsin
pb
min
supernat
contain
elut
scfv
phage
transfer
new
tube
inactiv
veev
particl
glycin
buffer
ph
ad
incub
rt
min
solut
neutral
phosphat
buffer
ph
elut
scfv
phage
use
titrat
describ
hust
et
al
remain
scfv
phage
amplifi
describ
hust
et
al
use
next
pan
round
second
pan
round
use
amplifi
phage
perform
follow
modif
amount
antigen
reduc
wash
cycl
pan
increas
addit
third
pan
round
amount
antibodi
phage
reduc
scfv
phage
furthermor
cell
cultur
supernat
noninfect
vero
cell
volum
use
competit
elisa
perform
microtitr
well
plate
nunc
coat
vr
purifi
viral
antigen
overnight
afterward
well
wash
three
time
pbst
block
wv
skim
milk
powder
pbst
mpbst
fetal
calf
serum
fc
pbst
h
rt
follow
three
wash
pbst
scfv
phage
solubl
antibodi
fragment
scfvfc
fusion
protein
dilut
mpbst
incub
antigen
h
follow
five
wash
pbst
bound
scfv
phage
detect
use
mab
conjug
horseradish
peroxidas
hrp
ge
healthcar
germani
bound
solubl
antibodi
fragment
detect
use
murin
mab
recogn
ctermin
cmyc
tag
stain
perform
goat
antimous
ab
conjug
hrp
sigma
specif
bind
scfvfc
fusion
protein
viral
antigen
assess
goat
antihuman
fc
specif
mab
conjug
hrp
sigma
biotinyl
mab
detect
use
streptavidin
hrp
conjug
ge
healthcar
visual
perform
tmb
substrat
stain
reaction
stop
ad
sulphur
acid
absorb
nm
measur
use
microtit
plate
reader
tecan
crailsheim
germani
microtitr
plate
well
contain
mm
glucos
ampicillin
inocul
singl
e
coli
coloni
phage
titrat
pan
incub
overnight
constant
shake
rpm
inocul
overnight
cultur
grown
rpm
h
bacteria
harvest
centrifug
min
g
pellet
resuspend
ampicillin
isopropylbetadthiogalactopyranosid
iptg
substanc
induc
prokaryot
lacz
promotor
e
coli
incub
rpm
overnight
cell
remov
scfv
contain
supernat
centrifug
min
g
sequenc
perform
use
abi
prism
genet
analyz
accord
manufactur
instruct
use
oligonucleotid
primer
mkpelbf
gcctacggcagccgctgg
mkmycr
gatcctcttctgagatgag
antibodi
gene
fragment
analyz
use
order
analys
scfv
present
phage
sdspage
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
scfv
phage
follow
western
blot
immunostain
piii
perform
describ
kirsch
et
al
scfvfc
fusion
protein
scfv
phage
use
detect
veev
protein
veev
particl
separ
sdspage
blot
onto
pvdf
membran
membran
block
mpbst
h
rt
scfv
phage
scfvfc
fusion
protein
incub
h
rt
follow
two
time
wash
pbst
detect
bound
scfv
phage
mab
mous
conjug
hrp
ge
healthcar
use
detect
visual
dab
diaminobenzidin
detect
scfvfc
fusion
protein
goat
antihuman
fc
specif
conjug
alcalin
phosphatas
ap
dianova
hamburg
germani
use
murin
igg
detect
use
goat
antimous
fc
specif
conjug
ap
sigma
visualis
nbtbcip
veevspecif
scfv
gene
fragment
subclon
librari
vector
mammalian
express
vector
schirrmann
manuscript
prepar
murin
igg
signal
peptid
human
gene
fragment
use
restrict
site
ncoi
noti
transient
product
veevspecif
scfvfc
fusion
protein
human
embryon
kidney
hek
cell
line
american
type
cultur
collect
atcc
rockwel
md
transient
transfect
use
cell
line
specif
lipid
transfect
reagent
hekfectin
biorad
germani
cell
seed
cultiv
overnight
six
well
tissu
cultur
plate
sarstedt
germani
ml
dulbecco
modifi
eagl
medium
dmem
supplement
mm
lglutamin
gl
sodium
bicarbon
gl
glucos
vv
fetal
calf
serum
fc
wv
penicillinstreptomycin
paa
pars
austria
atmospher
humid
transfect
plasmid
dna
encod
scfvfc
gene
construct
hekfectin
preincub
dmem
dnaliposom
complex
ad
hek
cell
cell
incub
overnight
transfect
mixtur
medium
exchang
fresh
one
follow
day
hour
cultur
supernat
contain
scfvfc
fusion
protein
harvest
scfvfc
fusion
protein
content
collect
supernat
analyz
use
human
igg
captur
elisa
previous
describ
mik
bh
perform
experi
help
draft
manuscript
cn
tr
perform
experi
addit
bh
particip
design
coordin
studi
ts
hjm
particp
design
coordin
studi
help
draft
manuscript
mh
draft
manuscript
particip
design
coordin
studi
perform
experi
sd
conceiv
project
wrote
grant
applic
particp
design
coordin
studi
help
draft
manuscript
author
read
approv
final
manuscript
